Are you considering banking your child’s cord blood? Let Americord answer all your questions about cord blood, from the cost of cord blood banking to what conditions can be treated with banked cord blood and stem cells.

1. INFORMATION KIT
cordadvantage.com 866-503-6005

2. cordadvantage.com
© Copyright 2013 Americord Registry V09172013
INFORMATION KIT
Why Americord?
Quality
• The best quality guarantee in the industry –
$80,000
• Registered with the FDA; AABB-accredited lab
• We use FDA-approved cord blood bags
suitable for C-sections without adaptors
• Executive Medical Director, Dr. Robert Draker,
is a leading hematologist and FDA Pediatrics
Advisory Committee member
Service
• 24/7 collection assistance for clients
• No annual storage fees for 20 years
• Cord tissue and placenta tissue banking
available
• Bedside pickup provided by a medical courier
at no extra charge
Price
Includes 20 years of storage - no annual fees
• Cord blood banking - $1,999
• Cord blood + tissue - $3,998
• Cord blood + cord tissue + placenta tissue -
$5,998
Umbilical cord blood stem cells
are easy and painless to collect,
easier to match (particularly with
siblings), and very flexible in
terms of the other types of cells
they can become.
Call 866-503-6005 to speak with
a cord blood specialist today or
visit us at cordadvantage.com
2008
120
100
80
60
40
20
0
2009 2010
Year
Source: 2012 Bioinformant Worldwide, LLC
DiseasesTreated
2011 2012 2013
?
Diseases treated using umbilical
cord blood stem cells since 2008
Did you know?
Stem cells are the body’s master cells
Stem cells are valuable in medical procedures because they have the ability to differentiate (change into
other types of cells in the body), which holds significant promise for improving the treatment of some of
the most common diseases, such as heart disease, diabetes, and Parkinson’s disease, just to name a few.
Cord blood is the most readily accessible source of stem cells
Cord blood, which is found in the umbilical cord, is an easily accessible source of stem cells that is only
available when a baby is born. The stem cells in the umbilical cord blood are genetically unique to your
baby and family and may be used to treat various medical problems for your child, his or her siblings,
and other family members.
The potential medical uses of stem cells
In addition to the growing list of diseases currently being treated with stem cells, several medical
research projects are showing encouraging results for new treatments.
• Stem cells have been “triggered” to differentiate into neural cells, which could lead to treatments
for diseases such as Alzheimer’s and Parkinson’s.
• Stem cells have proven their ability to turn into blood vessel cells, which could someday benefit
treatments for heart disease, allowing patients to essentially “grow their own bypass.”
• Stem cells have been labeled an important biological resource and researchers are conducting
studies to unlock the potential of stem cells in future applications for diseases like diabetes, heart
and liver disease, and muscular dystrophy, as well as for spinal cord injuries and stroke.

3. cordadvantage.com
© Copyright 2013 Americord Registry V09172013
INFORMATION KIT
Cord Blood Bank Comparison*
Don’t take our word for it. Hear what our customers think...
Cord Blood.
Simplified.
Credentials You
Can Trust
Americord
Registry
When I began researching cord
blood banks, I wanted to find the
one with the highest standards
– even if that meant I had to pay
more. What a great surprise to
find out that I could get the best
service and the highest quality at
half the price with Americord!
We are dedicated to making cord
blood banking simple by providing the
highest quality cord blood banking
services at the most affordable price.
Our price includes everything you need.
• 20 years storage and medical courier
• No hidden charges or annual fees
• $1,999 for cord blood or $3,998 for
cord blood and tissue
• We will match any competitor’s price
Americord is registered with
the FDA and our laboratory is
CLIA Certified, accredited by
the AABB, and complies with all
federal and state guidelines. We
use the only cord blood collection
bag approved by the FDA for all
births, including C-sections. We
use a medical courier to expedite
delivery of your baby’s cord blood
to our lab.
Americord collects, processes,
and stores newborn stem cells
from umbilical cord blood, cord
tissue, and placenta tissue for
future medical or therapeutic
use, including the treatment of
more than 80 diseases, such as
sickle cell anemia and leukemia.
Founded in 2008, Americord
operates in all 50 states.
Americord is headquartered in
New York, NY.
I had a million questions about cord
blood banking. The staff at Americord
answered them all and even explained
complicated things about stem cells
in plain language. They also walked
me through the different options and
payment plans and helped me find the
one that was right for me.
* ViaCord, CBR, Cryo-Cell, AlphaCord, StemCyte, and FamilyCord information is based on publicly available information from the
Parent's Guide to Cord Blood Banking website as of 12/4/2012. Visit cordadvantage.com/product-comparison for more information.
Included $150 $150$150+ $400+ $200+Included
ViaCord
Total Cord Blood Cost
Including 20 years storage
CBR Cryo-Cell AlphaCord StemCyte FamilyCord
$1,999
$4,625 $4,570 $4,245 $3,695
$4,675 $4,470
Total Cord Blood and Tissue Cost
Including 20 years storage
No Cancellation Fee
Quality Guarantee
Medical Courier Fee
$8,420 $7,655 $6,849
$7,970
$3,998
$80,000 $25,000 $50,000 $50,000 $50,000

4. cordadvantage.com
© Copyright 2013 Americord Registry V09172013
INFORMATION KIT
Cord tissue refers to the tissue of the umbilical cord. Until recently, cord tissue was often
discarded after birth, but new research has shown that the stem cells found in cord tissue
have the potential to treat many diseases. Cord tissue contains a specific kind of stem
cell, called mesenchymal stem cells (MSCs). Unlike the stem cells that are collected from
cord blood MSCs collected from cord tissue are multipotent, which means they have
the capacity to differentiate into many different types of cells, including cartilage cells
(chondrocytes), bone cells (osteoblasts), and fat cells (adipocytes). This characteristic of
MSCs means that they could potentially be used to treat a wide range of diseases.
Cord Blood vs. Cord Tissue
The stem cells in cord blood and cord tissue function differently. Cord blood contains hematopoietic
stem cells (HSCs), which form the blood-related cells in the body, such as white blood cells, red blood
cells, and platelets. There are over 80 diseases that have been treated using HSCs and almost 200
clinical trials are currently under way. Cord tissue contains stem cells known as mesenchymal stem cells
(MSCs), which develop into structural and connective tissue. There are currently over 40 clinical trials
under way investigating the potential therapeutic applications of MSCs from cord tissue.
Potential Uses
Though no conditions have been treated using
mesenchymal stem cells (MSCs), there are over 40
clinical trials under way. These clinical trials are exploring
the possibility of using MSCs for the following:
• Cartilage repair
• Liver disease
• Diabetes
• Stroke
• Heart disease
• Serious wounds
• Human Immunodeficiency Virus (HIV)
• Spinal cord injury
Cord blood banking, cord tissue banking, or placenta tissue banking does not guarantee that the saved cells will be applicable for every situation.
Ultimate use will be determined by a physician. Please note: Americord Registry’s activities are limited to collection of umbilical cord tissue from
autogeneic donors. Americord Registry’s possession of a New York State license for such collection does not indicate approval or endorsement of
possible future uses or future suitability of cells derived from umbilical cord tissue.
What
is Cord
Tissue?
2008
5
10
15
20
25
30
35
40
45
50
0
2009 2010
Year
Source: Bioinformant Worldwide, LLC
NumberofClinicalTrials
2011 2012 2013
?
Number of Clinical Trials Involving
Cord Tissue Since 2008

5. cordadvantage.com
© Copyright 2013 Americord Registry V09172013
INFORMATION KIT
The placenta is a stem cell rich tissue that protects the developing fetus in the womb.
Stem cells from placenta tissue are “immune-privileged,” meaning they are unlikely to be
rejected by human immune systems because they would never be recognized as a foreign
body. Cord blood, which is found in the umbilical cord, contains hematopoietic stem cells
(HSCs); umbilical cord tissue contains mesenchymal stem cells (MSCs). Placenta tissue
contains both HSCs and MSCs; in addition, the placenta contains pluripotent stem cells,
which are able to differentiate into almost any cell within the body. Because pluripotent
stem cells can develop into almost any cell, their use is constantly being researched for
the generation of new healthy cells that can replace diseased cells.
Pluripotent Stem Cells
Placenta tissue has been shown to be a rich source of pluripotent stem cells, or cells that have the
potential to differentiate into any cell in the body. This encompasses the cells that multipotent
stem cells can differentiate into, but the differentiation potential of pluripotent stem cells is
extended to include cells of the brain, lung, and liver. Pluripotent stem cells can be harvested and
used to regenerate virtually any cell. Because of this, pluripotent stem cells from from placenta
tissue hold the promise of someday being able to treat many neurological, respiratory, and
metabolic disorders.
Hematopoietic Stem Cells
Like cord blood, the tissue of the placenta is a rich source of hematopoietic stem cells (HSCs).
HSCs are cells that differentiate into blood-borne cells like red blood cells, white blood cells, and
platelets. Just like those derived from bone marrow and cord blood, HSCs from the placenta can
be used to treat over 80 diseases, including genetic disorders and cancers.
Mesenchymal Stem Cells
Placenta tissue is also an abundant source of mesenchymal stem
cells (MSCs). Unlike HSCs, MSCs are multipotent, which means
they can differentiate into a broader range of cells, including
cartilage cells, bone cells, and fat cells.
The potential therapeutic application of
MSCs to treat disease is currently the topic
of many research studies, with over 40
clinical trials under way. MSC research has
helped progress efforts to cure many still
untreatable diseases.
What
is the
Placenta?

6. cordadvantage.com
© Copyright 2013 Americord Registry V09172013
INFORMATION KIT
Why Cord Blood Stem Cells Are Better
Doctors may choose to use cord blood stem cells over bone marrow or peripheral blood stem cells
because of better survival outcomes. Cord blood stem cells are easier to match and present a lower
chance of resulting in graft-versus-host-disease (“GVHD”).
More Tolerant Matching
A close match between the patient and the donor can improve a patient’s outcome after
transplant. Bone marrow is difficult to match because it requires a “perfect match” between the
donor and recipient. Cord blood stem cells, however, are less mature than those in bone marrow
and can be successfully used even when there is only a half-match. This means there is more
opportunity for transplants between family members when cord blood is banked. Some studies
have shown that overall survival rates for transplants between relatives are more than double that
of transplants from unrelated donors.
Less Graft-Versus-Host Disease
Graft-versus-host disease (“GVHD”) is a common complication after an allogeneic transplant,
which uses cells from a family member or unrelated donor. GVHD can range from mild to life
threatening. Studies have found that fewer patients get GVHD after a cord blood transplant than
do after bone marrow or peripheral blood transplants.
Collecting Cord Blood, Cord Tissue, and Placenta Tissue Is Safe
Stem cells from cord blood, cord tissue, and placenta tisse are collected after your baby is
born and the umbilical cord has been cut. The collection of stem cells is painless, easy, and safe
for mother and baby. Cord blood, cord tissue, and placenta tissue collection will not alter the normal
birthing process in any way. The average collection time is about 5 to 10 minutes and is performed by
your medical professional.
Collection After C-Sections
Stem cells can be collected from the umbilical cord after C-section deliveries. Americord uses the
only FDA-approved sterile exterior cord blood collection bag that has been approved for ALL births,
including C-sections, without adaptors.
Who Should Consider Private Cord Blood Banking?
Saving stem cells is a once in a lifetime opportunity to expand your baby’s options for medical
treatment. Everyone can benefit from cord blood banking. It is often referred to as biological insurance
that hopefully you will never need. And with the rapid pace of medical advancement, the value of
banking your baby’s cord blood increases with time.
!

7. cordadvantage.com
© Copyright 2013 Americord Registry V09172013
INFORMATION KIT
It is prudent for parents to bank their baby’s cord blood if either parent has a family history of a disease
that is treatable with stem cells, such as leukemia, lymphoma, or myeloma. It has also been reported
that ethnic minorities and people of mixed ethnicity have greater difficulty finding a match from stem
cell donors, which makes private banking an important opportunity. Cord blood stems cells can be used
to treat certain genetic diseases, including sickle cell anemia and thalassemia, which are more common
in certain ethnic populations.
Families preparing to adopt a newborn should consider saving stem cells since, if they are ever
needed, the cord blood may be the only available genetic source of stem cells for the adopted baby. In
addition, if the baby’s family medical history is not available, stem cells might provide valuable medical
information. Similarly, couples using fertility treatments that involve a donor egg and/or sperm should
consider banking cord blood stem cells because this may be the only opportunity to secure a genetically
related sample of stem cells for their child.
Cord Blood Banking Controversy
Cord blood banking gives parents-to-be the best opportunity to offer their babies access to the most
advanced medical treatments, should they ever need them. However, some people consider cord blood
banking controversial.
It is true that the likelihood of using stem cells is very small. Banking stem cells from cord blood is often
referred to as biological insurance. It is an investment that puts the benefits of cutting-edge scientific
advances at your disposal. And, as medical research continues to uncover new uses of stem cells, the
likelihood that the stem cells could be used increases.
Some believe that public banking is better. Americord supports the availability of public
cord blood banking. However, private cord blood banking offers advantages that
public cord blood banking does not offer. Specifically, only through private cord
blood banking are you guaranteed immediate access to your baby’s own stem
cells. This means that you do not have to spend time searching for a match, nor
do you risk not finding a match.
Private cord blood banking is an additional expense that comes at a time
when many parents-to-be are thinking about other expenses, like the
child’s education or moving to a larger home. Americord is a strong
advocate for making cord blood banking affordable for everyone.
We suspect that insurance companies will help to cover the cost of
private cord blood banking in the future. We are also committed
to continuing to offer programs where we donate cord blood
banking services to low-income families. And, as more parents
elect to bank cord blood, the costs will come down.

8. cordadvantage.com
© Copyright 2013 Americord Registry V09172013
INFORMATION KIT
Top Benefits Of Private Cord Blood Banking
A Guaranteed Match
When you bank your baby’s cord blood you can rest easy knowing that if he or she ever needs a
medical treatment that uses stem cells, you have an exact match.
Quickly Available
Banking your baby’s cord blood ensures that these stem cells can be immediately available if they
are needed for treatment. A cord blood unit can be delivered from Americord’s storage facility to
a medical facility in less than two weeks. It can take two months or more to find an unrelated cord
blood, bone marrow, or peripheral blood donor through a public bank.
Selecting A Cord Blood Bank
Once you have made a decision to privately bank your baby’s cord blood, you will need to choose which
cord blood bank to use. Here are some of the key facts that you will want to consider:
• Is the cord blood bank registered with the FDA, accredited with the AABB, and licensed by the
state’s department of health?
• How and when is the cord blood collection kit delivered to you?
• How quickly will the cord blood be transferred to the laboratory for processing?
• Does the manufacturer of the cord blood collection kit have a substantial track record in the field?
• Does the collection kit contain everything that your medical practitioner will need to collect the
cord blood and package it for pickup by the courier?
• Does the cord blood collection kit contain clear instructions so you know what to do with it after
the cord blood has been collected?
• Does the cord blood bank use a medical courier service?
• Is the laboratory where the cord blood is processed appropriately accredited?
• What is the laboratory’s reputation in the industry?
• Is the stem cell storage facility used by the cord blood bank appropriately accredited?
• What is the stem cell storage facility’s reputation in the industry?
• Does the cord blood bank have a customer service hotline that is available 24/7 for any questions
related to cord blood collection and stem cell retrieval?

9. cordadvantage.com
© Copyright 2013 Americord Registry V09172013
INFORMATION KIT
Americord’s Executive Medical Director
Dr. Robert Dracker, a leading hematologist, pediatric oncologist, and recognized
blood and stem cell banking expert, is Americord’s Executive Medical Director. He
is responsible for all laboratory, collection, and transport protocols and procedures,
as well as licensing and accreditation. He is also responsible for quality controls
and advising Americord on all scientific and medical matters. Dr. Dracker previously
served as Executive Medical Director for ViaCord until 2007. He was also the Medical
Director of Biocyte, the cord blood company that facilitated the first cord blood
transplant in the United States. The cord blood collection and processing procedures
established by Biocyte (now known as PharmaStem) during Dr. Dracker’s tenure are
still used throughout the industry today. He was also part of the Working Group on
Cord Blood Stem Cell Guidelines for New York State and, as the Chairperson of the
Hematopoietic Progenitor Cell Committee for the NY State Department of Health,
an architect of the New York cord blood banking licensing requirements, which
are considered to be the gold standard of cord blood banking accreditations. Dr.
Dracker was recently named as a consultant to the Food and Drug Administration’s
(“FDA’s”) Pediatric Advisory Committee, which makes recommendations to the
Commissioner of Food and Drugs regarding research priorities, among other
responsibilities.
Americord’s Credentials And Protocols
Americord is a private cord blood bank that processes and stores newborns’ stem cells from cord
blood, cord tissue, and the placenta for future medical or therapeutic use. We are the only private
cord blood bank headquartered in New York City. We are deeply committed to offering our clients the
most valuable and scientifically advanced stem cell preservation service in the marketplace. Americord
is registered with the FDA and the company’s laboratory is accredited by the AABB. Our Executive
Medical Director, Dr. Dracker, is responsible for all laboratory, collection, and transport protocols
and procedures, as well as licensing and accreditation. Americord has developed the highest quality
protocols for every step of the process involved in the collection and storage of cord blood, cord tissue,
and placenta tissue from newborns.
When You Should Decide About Cord Blood Banking
Half of all babies arrive before their due date, so Americord recommends making a decision about cord
blood banking during your second trimester, if possible. However, it’s never too late in your pregnancy
to enroll.
Enrollment
Enrollment is quick and easy. Americord offers two methods for your convenience: online at
cordadvantage.com/enroll or by phone at 866-503-6005 extension 1.
Dr. Robert Dracker

10. cordadvantage.com
© Copyright 2013 Americord Registry V09172013
INFORMATION KIT
The Americord Collection Kit
Americord clients receive an Americord Collection Kit shortly after
enrollment. The Collection Kit contains all of the material your medical
practitioner will need to collect your baby’s cord blood. It also contains a pre-
labeled box that will be picked up by our medical courier. The phone number
to arrange for courier pickup is on the box. The umbilical cord blood collection
bag that is included in the Americord Collection Kit has become the industry
standard and is backed by standard operating procedures and clinical outcomes from the NIH COBLT
study. The Cord Blood Sterile Collection Bag is FDA-approved and designed to maximize the recovery
of cell-rich plasma. These sets are manufactured using validated manufacturing processes that ensure
safe, consistent, and reliable product performance. Each transplant bag is 100% inspected prior to
release. Your baby’s Collection Kit is assigned a unique identifier that always remains with your baby’s
Collection Kit, paperwork and sample. Additionally, a client ID label, which clearly identifies the client, is
attached to each sample.
When Your Baby Is Born
After your medical practitioner has made the collection using the Americord Collection Kit, the labor
and delivery staff will return the Collection Kit to you or to a designated family member. The Collection
Kit is pre-labeled and is ready to be shipped. Simply call Americord after your baby’s birth, and then
relax with your new baby. Your Collection Kit will be picked up by our medical courier directly from
your hospital room. After the medical courier picks up the Collection Kit, Americord will monitor your
shipment until it is safely delivered to our lab. While many other cord banks readily accept samples
delivered after 72 hours, this reduces the viability of the samples considerably; therefore Americord
aims to have the Collection Kit back to our laboratory within 24 hours or as quickly as possible. Unlike
other banks that use regular courier services, Americord only uses couriers that are trained to handle
time sensitive medical shipments using a consistent chain-of-custody. Americord’s medical courier
service is open and fully staffed 24 hours a day, 365 days a year. No matter when you deliver, your
baby’s Collection Kit is shipped under highly controlled conditions to our cord blood laboratory.
After Your Baby Is Born
Your baby’s stem cells are processed the same day your collection kit is received in our AABB-accredited
laboratory, even if it happens to be a holiday. Stem cell samples are tested for cell viability, total
nucleated cell count (TNC), sterility, infectious disease markers, number of stem cells, and blood type.
All processing and testing is performed following rigorous quality assurance procedures and under the
supervision of experienced staff. Laboratory staff is made up of highly experienced health professionals
and technicians who work under the guidance and expertise of our Executive Medical Director. This
ensures that Americord delivers the cutting-edge of new cord blood advances, while guaranteeing the
safety, integrity, and viability of your baby’s stem cells. Americord tests incoming cord blood samples
before and after processing as part of our quality control to ensure that each sample is contaminant-
free on arrival and continues to be during processing in our laboratory. Our screening exceeds FDA
regulations for testing and quality control.

11. cordadvantage.com
© Copyright 2013 Americord Registry V09172013
INFORMATION KIT
Stem Cells In Storage
Maintaining the viability and health of your baby’s stem cells throughout processing requires
careful lowering of the temperature prior to freezing and storage. Once the stem cells are
brought to the optimum temperature, they are placed in a storage cartridge and then into a storage
tank. Units are kept in designated freezers in a specifically designated storage area. Our AABB-
accredited laboratory’s sophisticated coding system offers easy and precise access to your cord blood
stem cells, should your family ever need them.
Americord uses Cook General BioTechnology LLC (“CGBT”) for all processing and storage of cord
blood. CGBT was founded in 1997 and is registered with the FDA as a Human Cell & Tissue Products
establishment. Its umbilical cord blood processing laboratories are licensed in New York, New Jersey,
California, Maryland and Indiana. Its facility, which is designed to meet and exceed the needs of its
customers, has been designed with features that include: multi-layer intrusion monitoring and video
surveillance; emergency power from an independent generator and a backup generator; smoke,
water, and fire detection monitoring; telephony for monitoring systems; reliable freezer temperature
monitoring; stand-by ULT and LN2 freezers; equipment calibrated with NIST traceable probes; facility
ambient temperature control; UPS battery backup systems for sensitive equipment.
When you enroll with Americord we ask you for your e-mail address, mailing address, and phone
number. Your baby’s Certificate of Storage will arrive via e-mail within one week. Should the need arise
for you to use your baby’s cord blood stem cells, Americord’s client services department and your
physician will make arrangements for confirmatory testing, release, and transportation of your baby’s
stem cells to a designated hospital.
Referral Program
Americord clients are encouraged to share their decision and experience with others. When you refer
your friends and family members to Americord you will receive a $50 gift card and the person you refer
will receive a $50 discount.

12. cordadvantage.com
© Copyright 2013 Americord Registry V09172013
INFORMATION KIT
Americord’s $80,000 Quality Guarantee
QUA
LITY GUARAN
TEE
$80,000
This guarantee is subject to the terms detailed in the enrollment agreement.
As a valued Americord client, the viability
of your baby’s umbilical cord blood stem
cells is backed by our $80,000 Quality
Guarantee. If your child’s cord blood unit is
used in a stem cell transplant and the cells
fail to engraft, Americord will pay $80,000
towards the cost of procuring stem cells
from an alternative source.

13. cordadvantage.com
© Copyright 2013 Americord Registry V09172013
INFORMATION KIT
Welcome to Americord registry
Thank you for taking the time to read through our information kit, we hope it answered all of your
questions. I’m proud that Americord Registry is the fastest growing, most competitive, and highest
quality cord blood bank in the industry.
You will soon be welcoming a new baby to this world and we want to make sure that you can do so
with the confidence of knowing that you’ve done everything possible to ensure a healthy future for
your child. It is our goal that you can do this at an affordable price. Please, do your research and if cord
blood banking seems like the right decision for your family, we will be here to make things easy for you.
You should note that Americord Registry is like no other cord blood bank in the world. We follow all
of the best practices, and meet or beat all industry standards. We offer the highest quality guarantee
at $80,000, an amount that has still not been matched by any of our competitors. We have the lowest
prices for both cord blood and cord tissue banking, and promise to meet any other cord blood bank’s
prices that beat our advertised price. We don’t charge an annual storage fee for 20 years and we wait
until we have verified that each cord blood collection exceeds strict industry benchmarks for cell count,
volume, and condition before charging our clients. Enrollment in Americord is risk-free. We do not
charge a cancellation fee if you decide not to bank your baby’s cord blood. And you can change your
product selection at any time since our 3-in-1-collection kit comes with the equipment necessary to
collect stem cells from cord blood, cord tissue, and placenta tissue.
Thank you once again for considering Americord. We hope to be able to serve you and your family.
Martin Smithmyer
President and CEO
Americord

14. cordadvantage.com
© Copyright 2013 Americord Registry V09172013
INFORMATION KIT
Acute Lymphoblastic Leukemia
Acute Myelogenous Leukemia
Acute Biphenotypic Leukemia
Acute Undifferentiated Leukemia
Chronic Myelogenous Leukemia
Chronic Lymphocytic Leukemia
Juvenile Chronic Myelogenous Leukemia
Juvenile Myelomonocytic Leukemia
Refractory Anemia
Refractory Anemia with Ringed Sideroblasts
Refractory Anemia with Excess Blasts
Refractory Anemia with Excess Blasts in Transformation
Chronic Myelomonocytic Leukemia
Hodgkin's Lymphoma
Beta Thalassemia Major (also known as Cooley's Anemia)
Blackfan-Diamond Anemia
Pure Red Cell Aplasia
Sickle Cell Disease
Severe Aplastic Anemia
Congenital Dyserythropoietic Anemia
Fanconi Anemia
Pure Red Cell Aplasia
Amegakaryocytosis / Congenital Thrombocytopenia
Glanzmann Thrombasthenia
Acute Myelofibrosis Agnogenic
Myeloid Metaplasia (Myelofibrosis)
Polycythemia Vera
Essential Thrombocythemia
Severe Combined Immunodeficiency (SCID)
SCID with Adenosine Deaminase Deficiency
SCID which is X-linked
SCID with absence of T & B Cells
SCID with absence of T Cells , Normal B Cells
Omenn Syndrome
Kostmann Syndrome
Myelokathexis
Ataxia-Telangiectasia
Bare Lymphocyte Syndrome
Common Variable Immunodeficiency
Leukemias
Lymphomas
Inherited Red Cell (Erythrocyte) Abnormalities
Other Disorders of Blood Cell Proliferation
Acute Leukemia
Chronic Leukemia
Myelodysplastic Syndromes (sometimes called pre-leukemia)
Anemias
Inherited Platelet Abnormalities
Myeloproliferative Disorders
Inherited Immune System Disorders
Inherited Immune System Disorders – Neutropenias
Inherited Immune System Disorders – Other
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
DiGeorge Syndrome
Leukocyte Adhesion Deficiency
Lymphoproliferative Disorders
Lymphoproliferative Disorder, X-linked (also known as
EpsteinBarr Virus Susceptibility)
Wiskott-Aldrich Syndrome
Chediak-Higashi Syndrome
Chronic Granulomatous Disease
Neutrophil Actin Deficiency
Reticular Dysgenesis
Multiple Myeloma
Plasma Cell Leukemia
Waldenstrom's Macroglobulinemia
Neuroblastoma
Retinoblastoma
Cartilage-Hair Hypoplasia
Gunther's Disease (Erythropoietic Porphyria)
Hermansky-Pudlak Syndrome
Pearson's Syndrome
Shwachman-Diamond Syndrome
Systemic Mastocytosis
Mucopolysaccharidoses Storage Diseases
Mucopolysaccharidoses (MPS)
Hurler's Syndrome (MPS-IH)
Scheie Syndrome (MPS-IS)
Hunter's Syndrome (MPS-II)
Sanfilippo Syndrome (MPS-III)
Morquio Syndrome (MPS-IV)
Maroteaux-Lamy Syndrome (MPS-VI)
Sly Syndrome, Beta-Glucuronidase Deficiency (MPS-VII)
Mucolipidosis II (I-cell Disease)
Adrenoleukodystrophy (ALD)/Adrenomyeloneuropathy (AMN)
Krabbe Disease (Globoid Cell Leukodystrophy)
Metachromatic Leukodystrophy
Pelizaeus-Merzbacher Disease
Gaucher Disease
Niemann-Pick Disease
Sandhoff Disease
Tay-Sachs Disease
Wolman Disease
Cancers in the Bone Marrow
Solid Tumors
Transplants for Inherited Disorders Affecting the
Immune System & Other Organs
Inherited Immune System Disorders – Other
Phagocyte Disorders
Transplants for Inherited Metabolic Disorders
Leukodystrophy Disorders
Lysosomal Storage Diseases
Inherited Disorders – Other
Lesch-Nyhan Syndrome
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
• Osteopetrosis
Diseases Treated With Cord Blood Stem Cells
n-Hodgkin's Lymphoma Burkitt's Lymphoma
Non-Hodgkin's Lymphoma Burkitt's Lymphoma
Source: Parent’s Guide to Cord Blood Foundation as of March 07, 2010. Please visit their web site for the most
current and comprehensive information.

15. cordadvantage.com
© Copyright 2013 Americord Registry V09172013
INFORMATION KIT
Human clinical trials Experimental Treatments
Crohn's Disease
Diabetes, Type 1 (formerly called Juvenile Diabetes)
Lupus
Cerebral Palsy, Hypoxia, Encephalopathy
Multiple Sclerosis
Traumatic Brain Injury
Spinal Cord Injury
Cystic Fibrosis
Histiocytic Disorders:
Familial Erythrophagocytic Lymphohistiocytosis
Hemophagocytosis
Langerhans Cell Histiocytosis (LCH; formerly called
Histiocytosis-X)
Epidermolysis Bullosa
Glanzmann Thrombasthenia
Severe Combined Immunodeficiency (SCID)
SCID with Adenosine Deaminase Deficiency (ADA-SCID)
SCID which is X-linked
Beta-Thalassemia
Wiskott-Aldrich Syndrome
Myocardial Infarction
Angina
Cardiomyopathy
Breast Cancer
Ewing's Sarcoma
Renal Cell Carcinoma
Restoring vision by growing a new cornea
Restoring vision by treating macular degeneration
o
o
o
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
Auto-Immune Diseases
Repair of the Nervous System
Disorders of Cell Proliferation or Metabolism
Gene Therapy
Cardiac Therapy
Transplants for Cancerous Tumors
Organ Repair
Arthritis, Juvenile
Arthritis, Rheumatoid
Evan Syndrome
Juvenile Dermatomyositis
Scleroderma
Fanconi's Anemia (using genetically modified cord blood
from the same person)
Metabolic Disorders
Parkinson's Disease
Duchenne Muscular Dystrophyuchenne Muscular Dystrophy
Amyotrophic Lateral Sclerosis (ALS, or "Lou Gehrig's disease")
Alzheimer's Disease
Huntington's Disease
Parkinson's Disease
Hearing loss
Stroke recovery
Combined transplant of kidney plus hematopoietic stem cells
Growth of renal cells from adult stem cells
Growth of liver cells from cord blood stem cells
Repair of liver cirrhosis with cord blood stem cells
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
• Growth of airway epithelia from stem cells in bone marrow
Auto-Immune Diseases
Gene Therapy
Nerve Cell Repair
Organ Repair
Diseases of the Central Nervous System
Other forms of nerve damage
Kidney
Liver
Lungs
Fanconi's Anemia (using genetically modified cord blood
Source: Parent’s Guide to Cord Blood Foundation as of March 07, 2010. Please visit their web site for the most
current and comprehensive information.